Antibiotic strategy in orofacial/head and neck infections in severe neutropenia.
A strategy for empiric antibiotic therapy for orofacial/head and neck bacterial infections that appear as clinical swellings in patients with severe neutropenia is assessed. Daily examinations were made in the hospital. Only those with peripheral blood neutrophil counts < 100/mm3 that persisted for at least 5 days after the commencement of resolution of the swelling were included in this article. The strategy consisted of sequential additions of a beta-lactam/aminoglycoside combination, metronidazole to intensify anaerobe cover and a beta-lactamase stable agent (such as vancomycin and floxacillin) as dictated by clinical signs. Progressive and complete resolution of infection occurred in 26 of 27 patients treated.
Barrett
A P
AP
Dental Clinical School Westmead Hospital, New South Wales, Australia.
Schifter
M
M
D000293:Adolescent; D000328:Adult; D000368:Aged; D000617:Aminoglycosides; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D001424:Bacterial Infections / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D002985:Clinical Protocols; D004359:Drug Therapy, Combination / Q000627:therapeutic use*; D004487:Edema; D005145:Face; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D007769:Lactams; D007938:Leukemia / Q000150:complications; D008223:Lymphoma / Q000150:complications; D008297:Male; D008795:Metronidazole / Q000008:administration & dosage; D008875:Middle Aged; D009059:Mouth Diseases / Q000188:drug therapy* / Q000382:microbiology; D009333:Neck; D009503:Neutropenia / Q000150:complications*; D010483:Periapical Diseases / Q000188:drug therapy; D010510:Periodontal Diseases / Q000188:drug therapy; D012189:Retrospective Studies; D012720:Severity of Illness Index; D016896:Treatment Outcome; D014640:Vancomycin / Q000008:administration & dosage
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D007769:Lactams; D008795:Metronidazole; D014640:Vancomycin